Healthcare - Medical - Devices - NASDAQ - US
$ 11.24
0.988 %
$ 912 M
Market Cap
-18.43
P/E
Price Target
Average
--8.81%
Revenue Forecast
Estimate
11.82%
EBIT
Estimate
31.44%
Net Income
Estimate
52.54%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Bioventus Inc.
Wall Street analysts predict an average 1-year price target for BVS of $10.2 , with forecasts ranging from a low of $8 to a high of $12 .
BVS Lowest Price Target
Wall Street Target
8 USD
-28.83%
BVS Average Price Target
Wall Street Target
10.2 USD
-8.81%
BVS Highest Price Target
Wall Street Target
12 USD
6.76%
REVENUE FORECAST
Revenue Forecast Chart BVS
EBIT FORECAST
EBIT Forecast Chart BVS
NET INCOME FORECAST
Net Income Chart BVS